References

  1. Huret JL, Bresson JL, Couet D, Tanzer J. Aberrant translocations in chronic myelogenous leukaemia with hidden chromosome 9 or 22 involvement. Ann Genet. 1987;30(3):175-7. PubMed | Google Scholar

  2. Huret JL. Complex translocations, simple variant translocations and Ph-negative cases in chronic myelogenous leukaemia. Hum Genet. 1990 Oct;85(6):565-8. PubMed | Google Scholar

  3. Marzocchi G, Castagnetti F, Luatti S, Baldazzi C et al. Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. Blood. 2011 Jun 23;117(25):6793-800. PubMed | Google Scholar

  4. Kubota Y, Waki M. Chronic myeloid leukemia with a novel four-way t(6;13;9;22)(p21;q32;q34;q11.2) successfully treated with imatinib mesylate. Cancer Genet Cytogenet. 2010 Sep;201(2):135-6. PubMed | Google Scholar

  5. Fitzgerald, P.H., Complex Ph translocations in chronic myeloid leukemia. Cancer Genet Cytogenet. 1991 Aug;55(1):129-31. PubMed | Google Scholar

  6. Baccarani M, Saglio G, Goldman J, Hochhaus A, et al. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2006 Sep 15;108(6):1809-20. PubMed | Google Scholar

  7. Ishihara T, Minamihisamatsu M. The Philadelphia chromosome - Considerations based on studies of variant Ph translocations. Cancer Genet Cytogenet. 1988 May;32(1):75-92. PubMed | Google Scholar

  8. Lamm SH, Engel A, Joshi KP, Byrd DM 3rd, Chen R. Chronic myelogenous leukemia and benzene exposure: a systematic review and meta-analysis of the case-control literature. Chem Biol Interact. 2009 Dec 10;182(2-3):93-7. PubMed | Google Scholar

  9. De Braekeleer M. Variant Philadelphia translocations in chronic myeloid leukemia. Cytogenet Cell Genet. 1987;44(4):215-22. PubMed | Google Scholar